HEALTHWTOP DC
Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue
Researchers are developing treatments and vaccines for hantavirus, a rare but deadly rodent-borne virus, despite limited funding. A drug for an autoimmune disease shows promise in combating hantavirus symptoms, and recent outbreaks, including on a cruise ship, have raised concerns about increased infections due to climate change.
Mentioned
hantavirustopicAndes virustopicChileplaceArgentinaplaceUnited StatesplaceDr. Fernando TortosapersonMaría Inés BarríapersonNational University of Río NegroorganizationUniversidad San SebastiánorganizationMinistry of Health (Chile)organizationU.S. Centers for Disease Control and Preventionorganization
Related Signal
Adjacent reporting
- Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue
- Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue
- A New Hantavirus Vaccine Is in the Works
- There is no vaccine for deadly hantavirus: what that means for future outbreaks
- There are no hantavirus treatments. The deadly cruise-ship outbreak is a ‘wake-up call’ to develop some.
- Ebola, hantavirus: Is the world prepared for the next pandemic?